U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06838845) titled 'An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adul... Read More
U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840847) titled 'Sexual Coercion in Breast Cancer Patients Treated With Luteinizing Hormone-Releasing Hormon... Read More
U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840054) titled 'The Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderat... Read More
U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840509) titled 'BIO|CONCEPT.CorSky, First in Human Study for the CorSky ICD Family' on Feb. 18. Brief Summ... Read More
U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06839937) titled 'A Virtual Reality Couples' Intervention for Sexual Victimization Prevention: a Gender-swapp... Read More
U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06838949) titled 'A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primar... Read More
U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06839638) titled 'Efficacy of 100% Trichloroacetic Acid Vs. Cryotherapy in Xanthelasma Palpebrarum' on Feb. 1... Read More
U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06839651) titled 'Umbilical Cord Mesenchymal Stem Cell Secretome in Severe Erectile Dysfunction Non-responsiv... Read More
U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06838754) titled 'Effect of Whole Body Vibration on Down Syndrome' on Nov. 03, 2024. Brief Summary: A congen... Read More
U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06839053) titled 'Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic ... Read More